Funding for this research was provided by:
Wellcome Trust (204969/Z/16/Z)
National Institute for Health Research (BRC)
Health Innovation Challenge Fund (R6-388 / WT 100127)
Text and Data Mining valid from 2019-07-25
Received: 7 January 2019
Accepted: 10 June 2019
First Online: 25 July 2019
Ethics approval and consent to participate
: Patients participated under the Molecular Genetic Analysis and Clinical studies of Individuals and Families at Risk of Genetic Disease (MGAC) protocol approved by West Midlands Research Ethics Committee, reference number 13/WM/0466. All patients gave informed, written consent. The study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare that they have no competing interests.